▎ 摘　　要

NOVELTY - A composition comprises graphene oxide and phenothiazine and/or phenothiazine. USE - Composition in the form of tablet or implantable composition used for treating psychiatric disease, inhibiting leukotriene biosynthesis, treating pain, reducing inflammation, and/or treating allergy, asthma and cardiovascular disorder (all claimed). DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: (1) a method for extending the release of phenothiazine and/or phenothiazine in a physiological environment comprising combining the phenothiazine and/or phenothiazine and graphene oxide; and (2) a method for converting phenothiazine to phenothiazine comprising contacting graphene oxide and phenothiazine to convert phenothiazine to phenothiazine.